Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 511–525 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-2633 Myeloproliferative Neoplasia (MPN) Extended Profile Test This test evaluates for mutations in the JAK2, CALR, and MPL genes, which are commonly associated with myeloproliferative neoplasms.	Whole blood (EDTA Lavender top tubes, 2× 4 mL)	6 working days (Monday sample, Saturday report)	2,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 V617F mutation", "CALR exon 9 mutations", "MPL exon 10 mutations"] Parameters [{"name": "JAK2 V617F", "reference_range": "Negative/Positive"}, {"name": "CALR exon 9", "reference_range": "Negative/Positive"}, {"name": "MPL exon 10", "reference_range": "Negative/Positive"}] Preparation ["No specific fasting required.", "Inform phlebotomist of all current medications."] Indications ["Diagnosis of polycythemia vera", "Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Differentiation from reactive conditions"] Measurement technique Confirm with laboratory Codes LOINC: 92848-8 ICD-10: D45, D47.3, D47.4 Clinical summary This test evaluates for mutations in the JAK2, CALR, and MPL genes, which are commonly associated with myeloproliferative neoplasms.
TEST-1311 Myeloproliferative Neoplasia (MPN) Genetic Panel Test This test identifies mutations in JAK2, CALR, MPL, and BCR-ABL1 genes using Next-Generation Sequencing (NGS) to diagnose and classify myeloproliferative neoplasms.	Peripheral Whole Blood	15 working days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["JAK2 gene mutations (V617F & exon 12)", "CALR gene mutations", "MPL gene mutations", "BCR-ABL1 gene fusion (quantitative)"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab about any current medications."] Indications ["Suspicion of myeloproliferative neoplasm (MPN)", "Diagnosis and classification of polycythemia vera, essential thrombocythemia, primary myelofibrosis", "Diagnosis of chronic myeloid leukaemia (CML)", "Monitoring treatment response in some cases"] Measurement technique Confirm with laboratory Codes LOINC: 92489-1 ICD-10: D47.1, D45, C92.1, D47.4 Clinical summary This test identifies mutations in JAK2, CALR, MPL, and BCR-ABL1 genes using Next-Generation Sequencing (NGS) to diagnose and classify myeloproliferative neoplasms.
TEST-5662 MYH7 Gene Scapuloperoneal Myopathy Genetic Test This test evaluates the MYH7 gene for pathogenic variants associated with scapuloperoneal myopathy and related neuromuscular disorders.	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the MYH7 gene", "Single nucleotide variants", "Indels", "Copy number changes"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of any medications"] Indications ["Suspected scapuloperoneal myopathy", "Suspected Emery-Dreifuss dystrophy", "Suspected familial cardiomyopathy", "Family history of MYH7-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 93928-0 ICD-10: G71.0 Clinical summary This test evaluates the MYH7 gene for pathogenic variants associated with scapuloperoneal myopathy and related neuromuscular disorders.
TEST-4242 MYLK2 Gene Sequencing for Hypertrophic Cardiomyopathy Test This test detects pathogenic variants in the MYLK2 gene associated with hypertrophic cardiomyopathy.	Peripheral whole blood (5–10 mL in EDTA tube)	3 to 4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in MYLK2 gene", "Single-nucleotide variants", "Small insertions or deletions"] Parameters [] Preparation ["No specific preparation required"] Indications ["Clinical suspicion of hypertrophic cardiomyopathy", "Family screening for hypertrophic cardiomyopathy"] Measurement technique Confirm with laboratory Codes LOINC: 82897-8 ICD-10: I42.1 Clinical summary This test detects pathogenic variants in the MYLK2 gene associated with hypertrophic cardiomyopathy.
TEST-3816 MYO1E Gene Focal Segmental Glomerulosclerosis Type 6 (FSGS6) DNA Test This diagnostic test evaluates the MYO1E gene for pathogenic mutations associated with autosomal recessive focal segmental glomerulosclerosis type 6 (FSGS6).	Peripheral whole blood (EDTA tube)	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the MYO1E gene", "Coding regions, splice sites, and intronic boundaries"] Parameters [] Preparation ["Mandatory genetic counselling session prior to sample collection", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected diagnosis of FSGS6", "Family history of FSGS6", "Genetic counselling for kidney disease"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: N04.2 Clinical summary This diagnostic test evaluates the MYO1E gene for pathogenic mutations associated with autosomal recessive focal segmental glomerulosclerosis type 6 (FSGS6).
TEST-1308 N-MYC Oncogene Test This test evaluates the amplification status of the MYCN oncogene in tumour tissue using Fluorescence In-Situ Hybridization (FISH). It is a critical prognostic marker for neuroblas...	Tumor Tissue (Fresh, Frozen, or Formalin-Fixed Paraffin-Embedded Blocks) – Archival Specimen	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["MYCN gene amplification", "Gene copy number"] Parameters [{"name": "MYCN Amplification Status", "reference_range": "Negative (No Amplification) / Positive (Amplification)"}, {"name": "Signal Ratio", "reference_range": "Reported as ratio (e.g., 1.5, 2.0, 4.0)"}] Preparation ["No specific patient preparation required.", "Ensure specimen collection is coordinated with the clinical team."] Indications ["Risk stratification in neuroblastoma", "Prognosis determination in neuroblastoma", "Evaluation of neural crest tumours"] Measurement technique Confirm with laboratory Codes LOINC: 33766-4 ICD-10: C74.90 Clinical summary This test evaluates the amplification status of the MYCN oncogene in tumour tissue using Fluorescence In-Situ Hybridization (FISH). It is a critical prognostic marker for neuroblastoma.
TEST-5998 NCL Enzyme Panel Genetic Test This genetic test identifies pathogenic variants in genes associated with Neuronal Ceroid Lipofuscinoses (NCL), a group of inherited metabolic disorders.	Peripheral Whole Blood (EDTA) or FTA Blood Spot Card	3 to 4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in NCL-associated genes", "Single nucleotide variants", "Small insertions/deletions"] Parameters [] Preparation ["No fasting required", "Genetic counselling session required to document family history"] Indications ["Diagnosis of suspected NCL", "Carrier screening for NCL", "Family planning for NCL risk"] Measurement technique Confirm with laboratory Codes LOINC: 101259-2 ICD-10: E75.4 Clinical summary This genetic test identifies pathogenic variants in genes associated with Neuronal Ceroid Lipofuscinoses (NCL), a group of inherited metabolic disorders.
TEST-5044 NDUFV1 Gene Mitochondrial Complex I Deficiency Genetic Test (NGS) This genetic test evaluates the NDUFV1 gene for pathogenic variants associated with mitochondrial complex I deficiency and related neurological disorders.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NDUFV1 gene sequence", "Pathogenic variants in NDUFV1"] Parameters [] Preparation ["No special preparation needed", "Inform phlebotomist about anticoagulant medications"] Indications ["Suspected Leigh syndrome", "Suspected mitochondrial encephalopathy", "Family history of mitochondrial disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21665-9 ICD-10: E88.49, G31.82 Clinical summary This genetic test evaluates the NDUFV1 gene for pathogenic variants associated with mitochondrial complex I deficiency and related neurological disorders.
TEST-2630 Neisseria gonorrhoeae Qualitative PCR Test This test detects the presence or absence of Neisseria gonorrhoeae DNA in a patient sample.	Urine or Genital Swab (Urethral/Endocervical)	Next-day report (samples received by 11 AM)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Neisseria gonorrhoeae DNA", "Opal gene (multicopy)"] Parameters [] Preparation ["Provide a first-morning urine sample", "Avoid urinating for at least 1 hour before collection", "Avoid douching or using vaginal creams for 24 hours prior (for swabs)"] Indications ["Symptomatic diagnosis", "Asymptomatic screening in at-risk populations", "Test-of-cure following treatment"] Measurement technique Confirm with laboratory Codes LOINC: 50387-0 ICD-10: A54.9, Z11.3, A54.00 Clinical summary This test detects the presence or absence of Neisseria gonorrhoeae DNA in a patient sample.
TEST-3984 Nephrology Panel Genetic Test This test screens for genetic mutations in over 300 genes linked to hereditary kidney diseases using Next-Generation Sequencing (NGS). It provides a comprehensive molecular diagnos...	Peripheral Whole Blood (or FTA Spot Card)	3–4 weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Genetic mutations in >300 kidney-related genes", "Variant analysis using AI-augmented database"] Parameters [] Preparation ["No special preparation needed"] Indications ["Diagnosis of hereditary kidney diseases", "Family screening for inherited kidney conditions", "Identifying genetic causes of nephrotic syndrome", "Evaluating suspected Alport syndrome or polycystic kidney disease"] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z13.6 Clinical summary This test screens for genetic mutations in over 300 genes linked to hereditary kidney diseases using Next-Generation Sequencing (NGS). It provides a comprehensive molecular diagnosis for conditions like Alport syndrome and polycystic kidney disease.
TEST-1307 Nervous System Cancer Gene Panel Test This test evaluates for germline mutations in multiple genes linked to hereditary brain and spinal cord tumors.	Peripheral whole blood (EDTA tube)	4–6 weeks	4,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Germline mutations in genes associated with hereditary nervous system cancers", "Presence of pathogenic variants in over 50 genes"] Parameters [] Preparation ["No specific fasting required.", "No special medication or diet restrictions."] Indications ["Individuals with a family history of brain or spinal cord tumors.", "Individuals with early-onset nervous system cancer.", "Individuals with multiple primary cancers.", "Individuals with certain clinical syndromes associated with increased risk."] Measurement technique Confirm with laboratory Codes LOINC: 81247-9 ICD-10: Z15.09 Clinical summary This test evaluates for germline mutations in multiple genes linked to hereditary brain and spinal cord tumors.
TEST-5974 NEU1 Gene Neuraminidase Deficiency Genetic Test This genetic test analyzes the NEU1 gene to detect mutations causing neuraminidase deficiency (sialidosis types I and II). It identifies variants like SNVs, indels, and CNVs using...	Peripheral Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NEU1 gene variants (SNVs, indels, CNVs)", "Zygosity status"] Parameters [{"name": "Sensitivity", "reference_range": ">99.9%"}, {"name": "Coverage Depth", "reference_range": "≥30x"}] Preparation ["No fasting required.", "No medication changes required unless directed by physician."] Indications ["Confirmation of neuraminidase deficiency (sialidosis)", "Family screening for at-risk individuals", "Assessment for therapeutic eligibility"] Measurement technique Confirm with laboratory Codes LOINC: 95025-7 ICD-10: E77.1 Clinical summary This genetic test analyzes the NEU1 gene to detect mutations causing neuraminidase deficiency (sialidosis types I and II). It identifies variants like SNVs, indels, and CNVs using Next-Generation Sequencing.
TEST-6073 NEUROD1 Gene MODY6 Genetic Test This test identifies sequence variants in the NEUROD1 gene to diagnose Maturity-Onset Diabetes of the Young type 6 (MODY6).	Whole Blood, Extracted DNA, or One Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["NEUROD1 gene sequence variants"] Parameters [] Preparation ["Genetic counseling session required", "No fasting required unless instructed by physician"] Indications ["Clinical suspicion of MODY", "Family history of MODY", "Early-onset diabetes"] Measurement technique Confirm with laboratory Codes LOINC: 79899-8 ICD-10: E13.9 Clinical summary This test identifies sequence variants in the NEUROD1 gene to diagnose Maturity-Onset Diabetes of the Young type 6 (MODY6).
TEST-4773 Neurofibromatosis Type 1 (NF1) Gene Genetic Test This diagnostic test evaluates the entire NF1 gene for pathogenic mutations associated with Neurofibromatosis Type 1.	Peripheral Whole Blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Mutations in the NF1 gene", "Point mutations", "Small insertions/deletions", "Copy number variants"] Parameters [] Preparation [] Indications ["Diagnosis of suspected NF1", "Familial risk assessment", "Personalized management", "Confirmation of clinical diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 97736-2 ICD-10: Q85.01 Clinical summary This diagnostic test evaluates the entire NF1 gene for pathogenic mutations associated with Neurofibromatosis Type 1.
TEST-3694 Neuromuscular Panel (NGS) Genetic Test This test evaluates over 200 genes associated with inherited neuromuscular disorders using Next-Generation Sequencing (NGS). It aims to provide a definitive molecular diagnosis for...	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	3,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Coding regions and splice sites of over 200 neuromuscular genes", "Genetic variants associated with inherited neuromuscular disorders"] Parameters [] Preparation [] Indications ["Suspected inherited neuromuscular disorder", "Diagnosis of muscular dystrophies", "Diagnosis of spinal muscular atrophy", "Diagnosis of hereditary motor and sensory neuropathies", "Diagnosis of congenital myasthenic syndromes", "Diagnosis of metabolic myopathies"] Measurement technique Confirm with laboratory Codes LOINC: 101247-9 ICD-10: G71.0, G71.9, G12.9, G60.9, G70.9 Clinical summary This test evaluates over 200 genes associated with inherited neuromuscular disorders using Next-Generation Sequencing (NGS). It aims to provide a definitive molecular diagnosis for conditions like muscular dystrophies and spinal muscular atrophy.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Molecular Diagnostics tests in Dubai & UAE

Molecular Diagnostics test prices

Molecular Diagnostics: overview

Use the test details as a conversation starter

Related Molecular Diagnostics categories